Was Harold Ruf’s 11,436-share OrthoPediatrics (KIDS) award an open-market purchase?

No. The transaction is coded as a grant or award acquisition at a price of $0.00 per share. This indicates a compensation-related equity award, not an open-market stock purchase on an exchange.

Stock award lifts OrthoPediatrics (KIDS) director Harold Ruf holdings

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ruf Harold reported acquisition or exercise transactions in this Form 4 filing.

OrthoPediatrics Corp director Harold Ruf reported a stock award of 11,436 shares of common stock. The award was granted at a price of $0.00 per share as equity compensation, not an open-market purchase.

Following the grant, Ruf directly holds 19,837 shares of common stock. The filing also reports indirect holdings of 2,400 shares through The Last Chance Legacy Trust and 19,247 shares through the Harald Ruf Roth IRA, where he is deemed to have a pecuniary interest under Section 16 regulations. Certain positions include restricted stock awards noted in the footnotes.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Ruf Harold

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 19,837 shares (Direct, null); Common Stock — 19,247 shares (Indirect, See Footnote)

Footnotes (1)

Includes restricted stock awards totaling 17,037 shares. Reflects shares held by The Last Chance Legacy Trust, dated April 3, 2023, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein. Includes restricted stock awards totaling 922 shares. Reflects shares held by the Harald Ruf Roth IRA.

Key Figures

Stock award: 11,436 shares Award price: $0.00 per share Direct holdings after grant: 19,837 shares +4 more

7 metrics

Stock award 11,436 shares Common stock grant coded as acquisition (A)

Award price $0.00 per share Equity compensation, not open-market purchase

Direct holdings after grant 19,837 shares Common stock held directly after transaction

Trust indirect holdings 2,400 shares Held by The Last Chance Legacy Trust

Roth IRA indirect holdings 19,247 shares Held by the Harald Ruf Roth IRA

Restricted stock included 17,037 shares Restricted stock awards included in one reported position

Additional restricted stock 922 shares Restricted stock awards included in another reported position

Key Terms

restricted stock awards, pecuniary interest, Section 16 regulations, beneficial ownership, +2 more

6 terms

restricted stock awards financial

"Includes restricted stock awards totaling 17,037 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

pecuniary interest financial

"in which he is deemed to have a pecuniary interest under Section 16 regulations."

Section 16 regulations regulatory

"in which he is deemed to have a pecuniary interest under Section 16 regulations."

beneficial ownership financial

"The reporting person disclaims beneficial ownership of the securities held by the trust"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Roth IRA financial

"Reflects shares held by the Harald Ruf Roth IRA."

A Roth IRA is a retirement savings account you fund with money that’s already been taxed, and withdrawals taken in retirement under the account rules are tax-free. It matters to investors because it shifts the tax bill to today instead of retirement, potentially increasing after-tax income later—think of it like paying for a lifetime subscription now so you can use it without extra charges in the future—helpful for long-term tax planning and flexibility.

grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/10/2026 - 09:49 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ruf Harold

(Last)

(First)

(Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW

INDIANA

46582

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/09/2026		A		11,436	A	$0	19,837⁽¹⁾	D
Common Stock								19,247⁽²⁾⁽³⁾	I	See Footnote
Common Stock								2,400⁽⁴⁾	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes restricted stock awards totaling 17,037 shares.

2. Reflects shares held by The Last Chance Legacy Trust, dated April 3, 2023, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein.

3. Includes restricted stock awards totaling 922 shares.

4. Reflects shares held by the Harald Ruf Roth IRA.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did OrthoPediatrics (KIDS) director Harold Ruf report in this Form 4?

Harold Ruf reported receiving 11,436 OrthoPediatrics common shares as a stock award. The filing also updates his direct and indirect share holdings, including positions held through a trust and a Roth IRA.

How many OrthoPediatrics (KIDS) shares were granted to Harold Ruf?

The filing shows a grant of 11,436 shares of OrthoPediatrics common stock. These shares were awarded at a stated price of $0.00 per share, indicating an equity compensation award rather than an open-market transaction.

What are Harold Ruf’s direct OrthoPediatrics (KIDS) holdings after the award?

After the stock award, Harold Ruf directly holds 19,837 shares of OrthoPediatrics common stock. This figure reflects his updated direct ownership position as of the transaction date reported in the Form 4 filing.

What indirect OrthoPediatrics (KIDS) holdings does Harold Ruf report?

The Form 4 reports 2,400 shares held indirectly through The Last Chance Legacy Trust and 19,247 shares held through the Harald Ruf Roth IRA. Ruf is deemed to have a pecuniary interest in these indirect holdings under Section 16 regulations.

Are restricted stock awards included in Harold Ruf’s OrthoPediatrics (KIDS) positions?

Yes. Footnotes state that certain reported holdings include restricted stock awards totaling 17,037 shares in one position and 922 shares in another. These restricted awards form part of the overall share counts disclosed in the Form 4.